To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
TPG's $800m pure equity stake in the country's biggest pharmaceutical distributor should allow the global buyout firm to tap into the fast-growing Russian market.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination